- Beat earnings estimates in all of the last 4 quarters
- Strong return on equity of 173,600.0%
- Highly efficient cash conversion (100% FCF/OCF ratio)
Evaluation of NeuroSense Therapeutics Ltd. stock downgraded after the last trading session
(Updated on Jun 02, 2026)
The NeuroSense Therapeutics Ltd. stock price fell by -1.57% on the last day (Tuesday, 2nd Jun 2026) from $0.81 to $0.80. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 8.01% from a day low at $0.780 to a day high of $0.84. The price has fallen in 6 of the last 10 days but is still up by 3.86% over the past 2 weeks. Volume has increased on the last day by 21 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 115 thousand shares were bought and sold for approximately $92.33 thousand.
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.84% during the next 3 months and, with a 90% probability hold a price between $0.722 and $0.98 at the end of this 3-month period.
NRSN Signals & Forecast
There are few to no technical positive signals at the moment. The NeuroSense Therapeutics Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.84 and $0.80. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -10.64%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). NeuroSense Therapeutics Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for NeuroSense Therapeutics Ltd. stock
NeuroSense Therapeutics Ltd. finds support from accumulated volume at $0.770 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0625 between high and low, or 8.01%. For the last week, the stock has had daily average volatility of 8.01%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (NRSN) For The Upcoming Trading Day Of Wednesday 3rd
For the upcoming trading day on Wednesday, 3rd we expect NeuroSense Therapeutics Ltd. to open at $0.81, and during the day (based on 14 day Average True Range), to move between $0.767 and $0.83, which gives a possible trading interval of +/-$0.0653 (+/-8.50%) up or down from last closing price. If NeuroSense Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 8.50% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.81 (1.11%) than the support at $0.770 (3.71%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is NeuroSense Therapeutics Ltd. stock A Buy?
The NeuroSense Therapeutics Ltd. stock holds several negative signals and despite the positive trend, we believe NeuroSense Therapeutics Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-2.628
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 3, 2026 - $0.81 ( 0.95%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
NRSN Performance
Trading levels for NRSN
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.87 | 8.76% |
| R2 | 0.85 | 5.77% |
| R1 | 0.83 | 3.93% |
| Price | 0.80 | |
| S1 | 0.784 | -2.04% |
| S2 | 0.769 | -3.88% |
| S3 | 0.745 | -6.87% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.90 | 12.24% |
| R2 | 0.81 | 1.40% |
| R1 | 0.81 | 1.11% |
| Price | 0.80 | |
| S1 | 0.770 | -3.71% |
| S2 | 0.762 | -4.75% |
| S3 | 0.730 | -8.75% |
FAQ
Click here for our free guide on how to buy NeuroSense Therapeutics Ltd. Stock.
Buy NRSN